When the count is falling, and the danger is not always in the number
This post walks through a real inpatient hematology consult, step by step, to show how experienced consultants organize their thinking over time. The phases are named explicitly to make visible what is usually implicit in practice.
The goal is not to provide an algorithm, but to model judgment as it unfolds.
Opening scenario
You are asked to consult on a hospitalized patient.
A 65-year-old man was admitted one week ago. During the course of his hospitalization, his platelet count has been falling. You are asked to see the patient because of concern about the low and decreasing platelet count.
No additional details are provided.
The scenario is deliberately spare. What follows is not a diagnostic walkthrough of this specific case, but a description of how consult reasoning actually unfolds, in stages, over time, and often with incomplete information.
Companion resources (in development)
Cause-based frameworks and quick-reference tools for common inpatient hematology problems are being developed as part of TBP’s consult reasoning series. They are meant to be used after initial orientation and framing, not in place of them.
How to use this post when you get paged
This is not a diagnostic guide, and it is not meant to be read linearly at the bedside.
Instead, use it as a cognitive checklist at three moments:
- When the page comes in, use Phase 1 to orient to danger, urgency, and asymmetric risk before naming diagnoses.
- When you make your first recommendation, use Phase 2 and 3 to decide what stance you’re taking and how to communicate it clearly under uncertainty.
- When new information arrives, use Phase 4 to recalibrate without rewriting history.
The disease examples that follow are not exhaustive. They are illustrations of how the same reasoning process adapts to different kinds of risk.
The goal is not to tell you what to think, but to help you recognize what kind of thinking the situation demands.
Different consults demand different kinds of thinking
Some hinge on thresholds, where the central question is whether inaction has become more dangerous than action. Others require balancing harms, where no option is safe and the work lies in choosing which risk to accept. Still others require proportionality, where the diagnosis is known and the challenge is matching the mechanism of an intervention to how the disease is behaving over time.
The disease examples that follow are not exhaustive. They are illustrations meant to help you recognize these patterns when you are in the middle of one.
Phase 1: Initial Orientation
(Often begins at the time of the page)
The first phase of consult reasoning is about orientation.
Before naming causes or ordering tests, the consultant identifies a small number of high-yield facts that immediately define urgency, risk, and the scope of what needs to be considered.
Phase 1 involves rapid, provisional thinking under time pressure, aimed at setting urgency and scope rather than committing to a diagnosis.
These questions define the clinical space you are working in. They determine how fast you need to move, how worried you should be, and what kinds of explanations even belong on the table, before any detailed evaluation begins.
Key orienting questions
(not ordered by importance)
Is the patient “sick”?
This deliberately nonspecific question carries enormous weight. It is shorthand for overall clinical stability: hemodynamics, mental status, bleeding, thrombosis, or signs of impending decompensation. The answer immediately influences urgency and risk tolerance.
Is there active bleeding or thrombosis?
Thrombocytopenia may signal hemorrhagic risk, thrombotic risk, or both. In many consults, this matters more than the platelet count itself.
Is thrombocytopenia isolated, or are other cytopenias or CBC abnormalities present?
This distinction rapidly narrows the field, separating platelet-focused processes from broader marrow, consumptive, or microangiopathic syndromes.
Where is the patient right now?
ICU, labor and delivery, post-operative unit, emergency department, or general medical floor. Clinical location alone often reshapes urgency and plausibility before any specialized testing is available.
How low is the platelet count, and how fast is it falling?
The absolute count and the trajectory together determine urgency and help prioritize next steps.
Is a procedure, anticoagulation decision, or transfusion being considered?
Many consults are fundamentally about safety rather than etiology. Clarifying this early often reveals the true question being asked.
At this stage, you are not explaining the thrombocytopenia.
You are defining urgency, risk, and scope.
By the end of Phase 1, the consultant should be able to say:
- I know how sick this patient is.
- I know whether I need to act immediately or have time to think.
- I know the clinical space I’m operating in.
- I know what kind of problem this is in broad terms (isolated vs systemic, urgent vs stable).
Phase 1 does not refine probabilities, weigh competing diagnoses, or decide between HIT, TTP, or DIC. Those come next.
Phase 2: Diagnostic Framing
(Choosing a direction of reasoning)
Phase 2 begins once you have oriented yourself to urgency and scope. The patient has been seen, the chart reviewed, and the initial panic, yours or the team’s, has settled.
In this phase, you are not committing to a diagnosis.
You are committing to a direction of reasoning.
The goal is to decide which explanations deserve serious attention right now, which can be deprioritized, and what information will matter most in narrowing the picture.
This is where the consultant makes pretest probabilities explicit, not as numbers, but as relative rankings.
What informs diagnostic framing
Several elements now come together:
- Clinical context and location
- Trajectory and degree of thrombocytopenia
- Whether thrombocytopenia is isolated or accompanied by other abnormalities
These factors often constrain the field substantially before any specialized testing is available.
At this stage, the consultant should be able to say, in broad terms:
- This explanation is highly plausible.
- These explanations are possible but less likely.
- These explanations are unlikely in this context.
That ranking, not diagnostic certainty, is the output of Phase 2.
Pretest probabilities, not premature closure
Pretest probabilities here are relative, not numeric. The purpose is not precision, but prioritization.
This framing determines what you actively worry about, what you monitor, and what would make you change course. It also determines how you interpret new data when it arrives.
The role of high-impact discriminators
Some tests have disproportionate influence once they return: peripheral smear review, HIT antibody testing, ADAMTS-13 activity, among others.
These tests are acknowledged in Phase 2, but often not yet available. Their absence at this moment is not because they are unimportant, but because they are pending.
If the smear were instantly available, it would be incorporated immediately. In practice, it often arrives hours later. Phase 2 respects that reality rather than forcing conclusions prematurely.
What Phase 2 does—and does not—do
Phase 2 does:
- rank competing explanations as low, medium, or high probability,
- define what you are most concerned about missing,
- identify which data will meaningfully shift your thinking.
Phase 2 does not:
- declare a final diagnosis,
- exhaustively list causes of thrombocytopenia,
- eliminate uncertainty.
The product of Phase 2 is a working diagnostic stance, explicit enough to guide action, flexible enough to revise.
That stance now needs to be communicated.
Phase 3: Communicating the Consult
(Expressing judgment clearly)
Phase 3 begins once you have a working diagnostic stance. You have not reached certainty, but you have enough orientation and framing to guide care.
The task now is communication.
Consult medicine is not only about reasoning well. It is about expressing judgment in a way that is clear, proportional, and trustworthy to the people who need to act on it.
Two audiences, two purposes
Internal communication (within the consult team)
This may involve a fellow presenting to an attending, or clinicians discussing the case together.
The goal here is not efficiency. It is calibration.
Internal communication is used to test interpretation, surface uncertainty, challenge assumptions, and align on concern and plan before speaking externally. This step protects against premature closure and the blind spots that come from reasoning alone.
External communication (to the primary team)
This is the consult service’s interface with patient care.
The goal here is not to demonstrate knowledge. It is to guide decisions.
Consultants, especially early in training, often default to encyclopedic presentations. Exhaustive lists and citations do not help the team act. They obscure priorities.
Effective consult communication should:
- clearly convey the level of concern,
- explain what is most likely and what is most dangerous,
- outline what is being done now and what is being watched for,
- match the strength of recommendations to the strength of evidence.
Clarity matters more than completeness.
Timing matters
Phase 3 communication usually occurs on the day of consultation, often before all data are available. That is appropriate.
The goal is not to wait for perfect information, but to provide a reasoned, transparent assessment that allows the team to move forward safely while uncertainty remains.
As new information arrives, this communication may need to be revisited. That evolution belongs to the next phase.
Phase 4: Recalibration Over Time
(Revising judgment as new information arrives)
Phase 4 begins when new, high-impact information becomes available.
This may occur hours or days later, when delayed or specialized tests return. These results do not just fill gaps. They can fundamentally change your assessment.
Phase 4 is about recalibration.
Good consult practice is not defined by getting everything “right” on day one. It is defined by the ability to revise judgment responsibly as new data arrive, and to make that revision visible, thoughtful, and proportional.
Recalibration is about timing, not better reasoning
The distinction between earlier phases and Phase 4 is not about the quality of thinking. It is about what information was available at the time.
Earlier phases rely on what can reasonably be inferred in real time. Phase 4 acknowledges that some results arrive later but deserve disproportionate weight once they do.
Communication revisited
When new information arrives, communication must be revisited as well.
Internal recalibration
New data should first be discussed internally, allowing interpretation in context and protecting against reflexive reactions to imperfect tests.
External update
Once recalibrated, the primary team must be updated. This may involve escalating urgency, de-escalating concern, changing management, or explaining why an empiric intervention is being continued, or stopped.
Changing one’s mind in response to new information is not a failure of reasoning. It is evidence of it.
What Phase 4 demands of the consultant
Phase 4 asks the consultant to revise judgment without rewriting history.
New information does not retroactively invalidate earlier decisions. Good consult practice requires explaining why prior actions were appropriate given what was known at the time, and why a different stance is warranted now.
This revision should be transparent rather than defensive. The best consultants are not those who never revise their thinking, but those who revise it clearly, proportionally, and without loss of credibility.
What recalibration looks like in practice depends on the disease.
Contrasting cases: Recalibration in HIT and TTP
The principles of recalibration take different forms depending on the disease. In some conditions, new data gradually shift probabilities and force reconsideration of earlier assumptions. In others, action precedes certainty, and later information determines whether that action should be continued or reversed. The following two cases—HIT and TTP—illustrate these contrasting patterns of consult judgment over time.
Heparin-induced thrombocytopenia (HIT): probabilistic recalibration
When I first saw this patient, HIT was plausible but not dominant.
The platelet count had fallen, but the timing was not classic. Heparin exposure had occurred, but was limited. Other explanations for thrombocytopenia fit the clinical context and competed meaningfully.
Diagnostic certainty was low.
At the same time, the risk was asymmetric. Missing HIT would be dangerous. Acting protectively carried less downside.
So we took protective action: heparin was stopped, a non-heparin anticoagulant was started, and HIT testing was sent.
That move did not reflect diagnostic confidence.
It reflected risk management.
Initial stance (before the antibody result)
Internally, our stance was explicit:
- HIT was possible, but not the leading explanation
- Other causes of thrombocytopenia were still competitive
- The diagnosis was unproven
- Our language needed to remain cautious and provisional
In other words:
HIT is possible enough that we must not ignore it, but not probable enough to fully commit.
That stance shaped how we spoke to the primary team. We did not declare HIT. We explained why we were acting protectively while uncertainty remained.
New information arrives: the HIT antibody
When the HIT antibody returned, the consult recalibrated.
What changed was not the diagnosis.
HIT had already been taken seriously enough to act against.
What changed was:
- the weight assigned to HIT relative to alternatives
- the confidence in continuing the protective strategy
- the threshold for reversing course
With a positive antibody, the same working hypothesis now carried more weight. Competing explanations fit less well. The provisional stance became firmer.
Internally, we discussed how strongly the result supported HIT in this context and whether any alternatives still plausibly explained the trajectory. Externally, we updated the team: given what we knew initially, our caution made sense; given what we know now, continued avoidance of heparin makes more sense.
If the antibody had returned negative, recalibration would have moved in the opposite direction.
The early protective action would still have been appropriate given the initial uncertainty. What would change is the confidence in maintaining that strategy. The weight would shift away from HIT, alternatives would rise, and the threshold for resuming heparin would lower.
What recalibration means in HIT
Recalibration in HIT is not:
- “we were wrong,” or
- “the test decided everything.”
It is:
The same working hypothesis now carries more or less weight, and our stance becomes firmer or looser in proportion.
That is real recalibration.
And it is fundamentally different from diagnostic error.
Thrombotic thrombocytopenic purpura (TTP): threshold-based recalibration
TTP forces a different kind of reasoning.
When this patient came to our attention, the central question was not diagnostic confidence. It was whether the risk of missing TTP was high enough to justify immediate action.
The constellation of findings crossed that threshold.
Internally, our stance was explicit:
- TTP was not proven
- Alternative explanations still existed
- Diagnostic certainty was low
- But the cost of waiting was unacceptably high
In other words:
The probability did not need to be high. The consequence of being wrong was.
Starting plasma exchange was not a declaration of certainty.
It was a declaration of concern.
That decision reflected risk management, not diagnostic closure.
When the ADAMTS-13 activity returned normal, effectively ruling out TTP, recalibration became necessary.
The difficult part was not recognizing the result. It was responding to it appropriately.
Internally, we agreed that continuing plasma exchange no longer made sense. Externally, we explained that starting therapy had been right given what we knew at the time, and stopping it now was also right given what we knew now.
The initial action was not a mistake.
The change in course was not a reversal.
Both were correct responses to different informational states.
What recalibration means in TTP
Recalibration in TTP is binary.
You cross a threshold to act before certainty, and later data determine whether you stay in that treatment state or exit it.
Unlike HIT, where recalibration strengthens or weakens commitment gradually, TTP demands an all-or-nothing response that is later confirmed or withdrawn.
Closing reflection
Across these four phases, consult reasoning unfolds as a process rather than a single act.
Urgency is defined before diagnosis.
Direction is chosen before certainty.
Judgment is communicated before completion.
And conclusions are revised as reality evolves.
What matters is not perfection at any single moment, but the ability to think, communicate, and recalibrate well over time.